Brief: BRAIN And SAMS Apply BEC Gene-Editing Technology
03/11/2021 09:06
Nov 3 (Reuters) - BRAIN BIOTECH AG BNNn.DE :
* BRAIN AND SAMS APPLY BEC GENE-EDITING TECHNOLOGY TO
OMEGA-3
COMPOUNDS FROM MARINE ORGANISMS
Source text for Eikon: ID:nEQVlxxza
Further company coverage: BNNn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt